Rare diseases
Investigational molecules
Locations
Study of hu14.18K322A with temozolomide and irinotecan in children and adolescents with high‑risk neuroblastoma
FranceStudy of Benralizumab Safety, Pharmacokinetics, and Efficacy in Children with Eosinophilic Disease
FranceA Phase 3 Study of Enpatoran to Treat Active Cutaneous Lupus in Patients With or Without Systemic Disease
FrancePhase 2 Study of PF-08634404 with Carboplatin and Etoposide in Adults with Untreated Small Cell Lung Cancer
FranceStudy of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors
FrancePhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
FranceRandomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients
FranceSafety and Feasibility of Home Use On-Body Injection System for Subcutaneous Ocrelizumab in Adults with Multiple Sclerosis
FranceWeekly Somatrogon versus Daily Somatropin in Children with Small for Gestational Age or Idiopathic Short Stature
FranceStudy of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer
FranceA Phase 2a Study Evaluating the Efficacy and Safety of MK-8690 in Adults with Moderately to Severely Active Ulcerative Colitis
FranceLong‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
